I would assume because the FDA would only accept blinded or double-blinded in certain scenarios (probably at the pointy Ph3 end)
Ann: Q3 2023 quarterly activity and cash flow report, page-16
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.78 |
Change
0.430(3.00%) |
Mkt cap ! $1.834B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $14.93 | $14.35 | $1.256M | 85.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 265 | $14.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.79 | 274 | 7 |
View Market Depth
| Last trade - 10.35am 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |